Breaking News Instant updates and real-time market news.

MYL

Mylan

$36.68

-0.17 (-0.46%)

, BMY

Bristol-Myers

$56.98

0.23 (0.41%)

07:31
11/28/16
11/28
07:31
11/28/16
07:31

Mylan signs sub-license agreement with Medicines Patent Pool

Mylan (MYL) announced that the company has signed an agreement with the Medicines Patent Pool to expand access to chronic hepatitis C medicines in developing countries. The agreement licenses Mylan to produce and market a generic version of Bristol-Myers Squibb's (BMY) DAKLINZA Tablets, 30 mg and 60 mg, for distribution in 112 low and middle income countries. Daclatasvir Tablets, 30 mg and 60 mg, are indicated for use with sofosbuvir, with or without ribavirin, for the treatment of patients with chronic hepatitis C virus genotype 1 or genotype 3 infection in the U.S. and genotype 1, 3 and 4 in Europe. The license allows Mylan to develop fixed-dose combinations that offer the potential to treat all of the six major genotypes of HCV. Earlier this year, the World Health Organization added several new hepatitis C treatments, including daclatasvir, to its essential medicines list, highlighting the urgent need to promote equitable access to innovative medicines.

MYL

Mylan

$36.68

-0.17 (-0.46%)

BMY

Bristol-Myers

$56.98

0.23 (0.41%)

  • 03

    Dec

  • 28

    Mar

MYL Mylan
$36.68

-0.17 (-0.46%)

10/10/16
WELS
10/10/16
NO CHANGE
WELS
Mylan settlement does not end EpiPen issue, says Wells Fargo
In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.
10/10/16
10/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Strong Buy from Market Perform at Raymond James with Elliot WIlbur saying the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. 2. Under Armour (UA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Tom Nikic saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales re-acceleration over the next 12-18 months. 3. Deere (DE) and AGCO (AGCO) were upgraded to Outperform from Market Perform at Wells Fargo. 4. Dow Chemical (DOW) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the merger with DuPont (DD) could gain regulatory approval and that the stock is "now too cheap to ignore." 5. Exelixis (EXEL) upgraded to Overweight from Neutral at Piper Jaffray with analyst Edward Tenthoff saying the data are "good enough" to file a supplemental new drug application and could drive off-label front-line RCC use. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/25/16
MZHO
10/25/16
INITIATION
Target $49
MZHO
Buy
Mylan initiated with a Buy at Mizuho
Mizuho analyst Irina Koffler initiated Mylan with a Buy and a $49 price target.
10/26/16
10/26/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mylan (MYL) initiated with a Buy at Mizuho. 2. Five Below (FIVE) initiated with a Buy at Longbow. 3. NetSuite (N) reinstated with an Underperform at BofA/Merrill. 4. Adient (ADNT) initiated with a Buy at Northcoast. 5. Party City (PRTY) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
BMY Bristol-Myers
$56.98

0.23 (0.41%)

10/28/16
HDLY
10/28/16
UPGRADE
HDLY
Long-Term Buy
Bristol-Myers upgraded to Long-Term Buy from Neutral at Hilliard Lyons
10/28/16
10/28/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Perform from Underperform at Oppenheimer with analyst Jason Helfstein saying the stock's valuation now "properly" reflects the challenging fundamental outlook. 2. Bristol-Myers (BMY) upgraded to Long-Term Buy from Neutral at Hilliard Lyons. 3. Qualcomm (QCOM) upgraded on valuation at BMO Capital with analyst Tim Long saying he is neutral on Qualcomm's acquisition of NXP (NXPI), but he expects Qualcomm's stock to stay in a trading range in the wake of the deal. 4. Level 3 (LVTL) upgraded to Outperform from Perform at Oppenheimer with analyst Timothy Horan saying the company has restructured itself in the last few years and now has operational/financial flexibility on free cash flow, with the analyst seeing accelerating growth in 2017. 5. ConocoPhillips (COP) upgraded to Overweight from Neutral at Piper Jaffray with analyst Guy Baber saying the company reported "another solid quarter." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/03/16
JPMS
11/03/16
NO CHANGE
JPMS
JPMorgan calls Lilly, Bristol-Myers, Allergan favorite pharma majors
Following a "challenging" Q3 earnings season for the major pharmaceuticals companies, JPMorgan analyst Chris Schott said pricing continues to be a major overhang on the space. However, he believes these and other challenges are "increasingly well reflected" in both earnings and sector multiples and recommends companies early in new product launch cycles. Coming out of the earnings season, Schott named Eli Lilly (LLY), Bristol-Myers (BMY) and Allergan (AGN) as his favorite names in the large-cap pharma space.
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.

TODAY'S FREE FLY STORIES

11:06
12/08/16
12/08
11:06
12/08/16
11:06
General news
The Fly announces rebranding, launch of new website »

The Fly, formerly known…

BA

Boeing

$155.03

0.89 (0.58%)

11:03
12/08/16
12/08
11:03
12/08/16
11:03
Hot Stocks
Boeing reports two new 787 orders in weekly update »

Boeing on its website…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$45.15

0.1639 (0.36%)

11:03
12/08/16
12/08
11:03
12/08/16
11:03
Hot Stocks
Agilent, Transcriptic collaborate to automate discovery biology »

Agilent Technologies and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APOL

Apollo Education

$9.52

0.01 (0.11%)

, DV

DeVry

$31.48

0.325 (1.04%)

11:01
12/08/16
12/08
11:01
12/08/16
11:01
Hot Stocks
Apollo Education slides after DoE response to preacquisition review application »

Shares of for-profit…

APOL

Apollo Education

$9.52

0.01 (0.11%)

DV

DeVry

$31.48

0.325 (1.04%)

ESI

ITT Educational

EDMC

Education Management

$0.01

0.001 (11.11%)

CECO

Career Education

$10.22

-0.03 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Dec

ASUR

Asure Software

$8.38

0.37 (4.62%)

11:01
12/08/16
12/08
11:01
12/08/16
11:01
Conference/Events
Asure Software management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Dec

BA

Boeing

$154.95

0.81 (0.53%)

11:01
12/08/16
12/08
11:01
12/08/16
11:01
Hot Stocks
Boeing begins final assembly on first 787-10 Dreamliner »

Boeing teammates in North…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNR

Harvest Natural

$5.46

-0.19 (-3.36%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Periodicals
Harvest Natural mentioned cautiously by TheStreetSweeper »

TheStreetSweeper's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

DISH

$58.64

0.13 (0.22%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Technical Analysis
DISH spikes off session lows »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$96.87

-1 (-1.02%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Conference/Events
Arista Networks management to meet with Pacific Crest »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

NFLX

Netflix

$125.39

0.82 (0.66%)

11:00
12/08/16
12/08
11:00
12/08/16
11:00
Options
Netflix short-term calls are active »

Netflix short-term calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
12/08/16
12/08
11:00
12/08/16
11:00
General news
Treasury futures action: some block buying »

Treasury futures action:…

AMAT

Applied Materials

$32.51

0.9 (2.85%)

10:58
12/08/16
12/08
10:58
12/08/16
10:58
Conference/Events
Applied Materials management to meet with Stifel »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DISH

DISH

$58.64

0.13 (0.22%)

10:57
12/08/16
12/08
10:57
12/08/16
10:57
Rumors
Rumor moving shares of DISH »

Rumor: DISH active amid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
12/08/16
12/08
10:55
12/08/16
10:55
Conference/Events
Stifel electrical equipment analysts to hold a luncheon meeting »

Electrical, Networking…

IWM

iShares Trust Russell 2000 Index Fund

$136.53

0.625 (0.46%)

, RUT

Russell 2000 Index

10:53
12/08/16
12/08
10:53
12/08/16
10:53
Technical Analysis
Russell 2000 Index hits new life high »

The index was last at…

IWM

iShares Trust Russell 2000 Index Fund

$136.53

0.625 (0.46%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.22

-0.24 (-0.28%)

10:50
12/08/16
12/08
10:50
12/08/16
10:50
Options
Notable put activity in the High Yield Bond Fund »

Notable put activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$241.93

-5.21 (-2.11%)

10:45
12/08/16
12/08
10:45
12/08/16
10:45
Technical Analysis
Northrop Grumman trades lower, levels to watch »

Shares are down over 2.3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$11.03

0.24 (2.22%)

10:45
12/08/16
12/08
10:45
12/08/16
10:45
Options
AK Steel call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/08/16
12/08
10:45
12/08/16
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
12/08/16
12/08
10:45
12/08/16
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

EXA

Exa Corp.

$14.44

-0.36 (-2.43%)

10:44
12/08/16
12/08
10:44
12/08/16
10:44
Conference/Events
Exa Corp. to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

$60.65

0.31 (0.51%)

10:40
12/08/16
12/08
10:40
12/08/16
10:40
Conference/Events
ResMed management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

ESPR

Esperion

$11.50

-0.18 (-1.54%)

10:38
12/08/16
12/08
10:38
12/08/16
10:38
Conference/Events
Esperion management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

LPLA

LPL Financial

$37.94

0.97 (2.62%)

10:37
12/08/16
12/08
10:37
12/08/16
10:37
Periodicals
Breaking Periodicals news story on LPL Financial »

LPL Financial said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EROS

Eros International

$14.18

0.375 (2.72%)

10:36
12/08/16
12/08
10:36
12/08/16
10:36
Conference/Events
Eros International management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.